Hyphen BioMed recalls ZYMUTEST HIA IgGAM; REF Number: RK040D; UDI: 03663537018770 a qualitative screening assay intended for the global detec…
- Recall date
- February 5, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1744-2018
- FDA classification
- Class II
- Brand / firm
- Hyphen BioMed
- Sold / distributed
- OH, MD, NC, NY, NH, Canada, Sweden
Why it was recalled
Incorrect package insert indicating use of the kits with plasma, serum, and other biological fluids. The kits should only be used with plasma.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
ZYMUTEST HIA IgGAM; REF Number: RK040D; UDI: 03663537018770 a qualitative screening assay intended for the global detection of heparin- dependent antibodies, whether the isotype is: IgG, IgM and IgA, in human plasma, by clinical laboratories.
Get recall alerts
Free email alert whenever Hyphen BioMed has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Hyphen BioMed